NASDAQ:NEOG - Neogen Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$62.64 -0.35 (-0.56 %)
(As of 02/19/2019 04:00 PM ET)
Previous Close$62.99
Today's Range$61.96 - $62.97
52-Week Range$52.10 - $97.38
Volume137,002 shs
Average Volume211,630 shs
Market Capitalization$3.26 billion
P/E Ratio51.77
Dividend YieldN/A
Beta1.34
Neogen Corporation, together with its subsidiaries, develops, manufactures, and markets various products for food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment primarily offers diagnostic test kits and complementary to detect dangerous and/or unintended substances in human food and animal feed, such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test for adenosine triphosphate, a chemical found in living cells. This segment offers its products primarily to food and feed, and grain processors and processors; meat and poultry processors, seafood processors, fruit and vegetable producers, and dairies; laboratories; and producers of pharmaceuticals, cosmetics, veterinary vaccines, and nutraceutical products. The Animal Safety segment provides veterinary instruments, pharmaceuticals, vaccines, topical and diagnostic products, rodenticides, cleaners, disinfectants, insecticides, and genomics testing services for the animal safety market. This segment offers various products for researchers to detect biologically active substances. Its drug detection immunoassay test kits are used for the detection of abused and therapeutic drugs in farm and racing animals; detection of drug residues in meat and meat products; and human forensic toxicology drug screening applications. In addition, this segment's products are also used to maintain sanitary conditions and limit the potential hazards of bacteria, fungi, and viruses. The company sells its products directly, as well as through distributors and retail chains. Neogen Corporation was founded in 1981 and is headquartered in Lansing, Michigan.

Receive NEOG News and Ratings via Email

Sign-up to receive the latest news and ratings for NEOG and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Diagnostic substances
Sub-IndustryHealth Care Supplies
SectorMedical
Current SymbolNASDAQ:NEOG
CUSIP64049110
Phone517-372-9200

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$402.25 million
Cash Flow$1.5680 per share
Book Value$10.86 per share

Profitability

Net Income$63.14 million

Miscellaneous

Employees1,546
Market Cap$3.26 billion
OptionableOptionable

Neogen (NASDAQ:NEOG) Frequently Asked Questions

What is Neogen's stock symbol?

Neogen trades on the NASDAQ under the ticker symbol "NEOG."

When did Neogen's stock split? How did Neogen's stock split work?

Shares of Neogen split before market open on Tuesday, January 2nd 2018. The 4-3 split was announced on Friday, December 8th 2017. The newly issued shares were issued to shareholders after the closing bell on Friday, December 29th 2017. An investor that had 100 shares of Neogen stock prior to the split would have 133 shares after the split.

How will Neogen's stock buyback program work?

Neogen declared that its board has initiated a stock repurchase plan on Wednesday, October 10th 2018, which permits the company to buyback 3,000,000 shares, according to EventVestor. This buyback authorization permits the company to purchase shares of its stock through open market purchases. Stock buyback plans are usually a sign that the company's board believes its shares are undervalued.

How were Neogen's earnings last quarter?

Neogen Co. (NASDAQ:NEOG) announced its quarterly earnings data on Thursday, December, 20th. The company reported $0.31 EPS for the quarter, beating analysts' consensus estimates of $0.30 by $0.01. The company had revenue of $107.10 million for the quarter, compared to analysts' expectations of $108.52 million. Neogen had a return on equity of 11.45% and a net margin of 15.88%. The company's quarterly revenue was up 6.4% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.33 earnings per share. View Neogen's Earnings History.

When is Neogen's next earnings date?

Neogen is scheduled to release their next quarterly earnings announcement on Thursday, March 28th 2019. View Earnings Estimates for Neogen.

What price target have analysts set for NEOG?

3 analysts have issued 1-year price objectives for Neogen's shares. Their forecasts range from $60.00 to $65.00. On average, they anticipate Neogen's share price to reach $62.50 in the next twelve months. This suggests that the stock has a possible downside of 0.2%. View Analyst Price Targets for Neogen.

What is the consensus analysts' recommendation for Neogen?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Neogen in the last year. There are currently 3 hold ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Neogen.

Has Neogen been receiving favorable news coverage?

Media headlines about NEOG stock have trended somewhat positive recently, InfoTrie Sentiment Analysis reports. InfoTrie identifies negative and positive media coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Neogen earned a news impact score of 0.9 on InfoTrie's scale. They also gave media coverage about the company a news buzz of 4.0 out of 10, indicating that recent media coverage is somewhat unlikely to have an effect on the stock's share price in the near term.

Who are some of Neogen's key competitors?

Who are Neogen's key executives?

Neogen's management team includes the folowing people:
  • Mr. James L. Herbert, Exec. Chairman (Age 79)
  • Mr. John Edward Adent, CEO & Pres (Age 51)
  • Mr. Steven J. Quinlan, VP, CFO & Sec. (Age 57)
  • Ms. Terri A. Morrical, VP of Animal Safety Operations (Age 54)
  • Mr. Rod Poland, Director of Corp. Communications

Who are Neogen's major shareholders?

Neogen's stock is owned by a variety of of institutional and retail investors. Top institutional investors include BlackRock Inc. (14.25%), Conestoga Capital Advisors LLC (2.92%), Riverbridge Partners LLC (1.74%), New York State Common Retirement Fund (1.65%), King Luther Capital Management Corp (1.56%) and Northern Trust Corp (1.38%). Company insiders that own Neogen stock include Edward Bradley, G Bruce Papesh, Jack C Parnell, James L Herbert, James P Tobin, John Edward Adent, Ronald D Green, Steven J Quinlan, Terri A Morrical, Thomas H Reed and William T Boehm. View Institutional Ownership Trends for Neogen.

Which major investors are selling Neogen stock?

NEOG stock was sold by a variety of institutional investors in the last quarter, including King Luther Capital Management Corp, PNC Financial Services Group Inc., Riverbridge Partners LLC, Barclays PLC, BlackRock Inc., Principal Financial Group Inc., Two Sigma Advisers LP and MetLife Investment Advisors LLC. Company insiders that have sold Neogen company stock in the last year include Edward Bradley, G Bruce Papesh, Jack C Parnell, James L Herbert, Steven J Quinlan, Terri A Morrical, Thomas H Reed and William T Boehm. View Insider Buying and Selling for Neogen.

Which major investors are buying Neogen stock?

NEOG stock was purchased by a variety of institutional investors in the last quarter, including WINTON GROUP Ltd, Ardevora Asset Management LLP, Eagle Asset Management Inc., Ranger Investment Management L.P., Conestoga Capital Advisors LLC, Geode Capital Management LLC, Dimensional Fund Advisors LP and SG Americas Securities LLC. Company insiders that have bought Neogen stock in the last two years include James P Tobin and John Edward Adent. View Insider Buying and Selling for Neogen.

How do I buy shares of Neogen?

Shares of NEOG can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Neogen's stock price today?

One share of NEOG stock can currently be purchased for approximately $62.64.

How big of a company is Neogen?

Neogen has a market capitalization of $3.26 billion and generates $402.25 million in revenue each year. The company earns $63.14 million in net income (profit) each year or $1.21 on an earnings per share basis. Neogen employs 1,546 workers across the globe.

What is Neogen's official website?

The official website for Neogen is http://www.neogen.com.

How can I contact Neogen?

Neogen's mailing address is 620 LESHER PLACE, LANSING MI, 48912. The company can be reached via phone at 517-372-9200 or via email at [email protected]


MarketBeat Community Rating for Neogen (NASDAQ NEOG)

Community Ranking:  2.1 out of 5 (star star)
Outperform Votes:  251 (Vote Outperform)
Underperform Votes:  342 (Vote Underperform)
Total Votes:  593
MarketBeat's community ratings are surveys of what our community members think about Neogen and other stocks. Vote "Outperform" if you believe NEOG will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NEOG will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/19/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel